PL3278811T3 - Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych - Google Patents
Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowychInfo
- Publication number
- PL3278811T3 PL3278811T3 PL17187879T PL17187879T PL3278811T3 PL 3278811 T3 PL3278811 T3 PL 3278811T3 PL 17187879 T PL17187879 T PL 17187879T PL 17187879 T PL17187879 T PL 17187879T PL 3278811 T3 PL3278811 T3 PL 3278811T3
- Authority
- PL
- Poland
- Prior art keywords
- ggf2
- neuropathic pain
- peripheral nerve
- nerve injury
- treat neuropathic
- Prior art date
Links
- 208000010886 Peripheral nerve injury Diseases 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261618381P | 2012-03-30 | 2012-03-30 | |
| US201261674060P | 2012-07-20 | 2012-07-20 | |
| US201261693585P | 2012-08-27 | 2012-08-27 | |
| US201261693589P | 2012-08-27 | 2012-08-27 | |
| US201361785419P | 2013-03-14 | 2013-03-14 | |
| EP17187879.6A EP3278811B1 (en) | 2012-03-30 | 2013-03-29 | Use of ggf2 to treat neuropathic pain upon peripheral nerve injury |
| EP13716919.9A EP2830645B1 (en) | 2012-03-30 | 2013-03-29 | Neuregulin for use in treating peripheral nerve injury |
| PCT/US2013/034634 WO2013149163A1 (en) | 2012-03-30 | 2013-03-29 | Use of neuregulin to treat peripheral nerve injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3278811T3 true PL3278811T3 (pl) | 2021-08-02 |
Family
ID=48128617
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17187879T PL3278811T3 (pl) | 2012-03-30 | 2013-03-29 | Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych |
| PL13716919T PL2830645T3 (pl) | 2012-03-30 | 2013-03-29 | Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13716919T PL2830645T3 (pl) | 2012-03-30 | 2013-03-29 | Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20150094263A1 (enExample) |
| EP (3) | EP2830645B1 (enExample) |
| JP (4) | JP6420233B2 (enExample) |
| CN (2) | CN104321072A (enExample) |
| AU (4) | AU2013237896B2 (enExample) |
| BR (1) | BR112014024308B1 (enExample) |
| CA (1) | CA2869070A1 (enExample) |
| DK (2) | DK3278811T3 (enExample) |
| ES (2) | ES2647917T3 (enExample) |
| IL (3) | IL288785B2 (enExample) |
| MX (1) | MX354598B (enExample) |
| NZ (1) | NZ700546A (enExample) |
| PL (2) | PL3278811T3 (enExample) |
| PT (2) | PT2830645T (enExample) |
| WO (1) | WO2013149163A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3338791T3 (da) | 2008-07-17 | 2019-12-16 | Acorda Therapeutics Inc | Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt |
| PL3235504T3 (pl) | 2009-10-14 | 2020-03-31 | Acorda Therapeutics, Inc. | Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego |
| ITUB20155471A1 (it) * | 2015-11-11 | 2017-05-11 | Univ Degli Studi Di Torino | Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici |
| IL294038A (en) * | 2015-12-04 | 2022-08-01 | Univ Iowa Res Found | Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium |
| CA3082878C (en) | 2017-11-17 | 2024-02-20 | The Research Foundation for State University of New York | A method for treating damaged peripheral nerves using x-ray microbeam irradiation |
| CN110946991A (zh) * | 2018-09-27 | 2020-04-03 | 广州中医药大学(广州中医药研究院) | 神经调节蛋白1的应用 |
| CN114929099B (zh) * | 2019-08-01 | 2025-08-15 | 马克·埃文斯 | 用于在分娩期间和分娩之前降低人类胎儿神经损伤风险及鉴定神经损伤存在的方法和设备 |
| CN116116737B (zh) * | 2023-04-14 | 2023-06-30 | 新华手术器械有限公司 | 止血钳毛坯自动上料装置及使用方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US888A (en) | 1838-08-20 | perkins | ||
| US7037A (en) | 1850-01-22 | Grid-ikon slide-valve | ||
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US6087323A (en) * | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| EP1028735A4 (en) * | 1997-10-14 | 2003-08-06 | Cenes Pharmaceuticals Inc | THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN |
| CA2409996C (en) * | 2000-05-23 | 2016-03-01 | Cenes Pharmaceuticals, Inc. | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| WO2009046453A2 (en) * | 2007-10-05 | 2009-04-09 | New England Medical Center (Nemc) | Use of neuregulin-1 in reducing brain damage |
| CN104645315A (zh) * | 2008-02-29 | 2015-05-27 | 阿索尔达治疗公司 | 达到所需胶质生长因子2血浆水平的方法 |
| DK3338791T3 (da) * | 2008-07-17 | 2019-12-16 | Acorda Therapeutics Inc | Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt |
| KR101237927B1 (ko) * | 2009-05-07 | 2013-03-04 | (주)문엔제이 | 신경손상 및 신경질환 예방 또는 치료용 약학조성물 |
| PL3235504T3 (pl) * | 2009-10-14 | 2020-03-31 | Acorda Therapeutics, Inc. | Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego |
| CA2845198A1 (en) * | 2010-08-13 | 2012-02-16 | Georgetown University | Ggf2 and methods of use |
-
2013
- 2013-03-29 DK DK17187879.6T patent/DK3278811T3/da active
- 2013-03-29 AU AU2013237896A patent/AU2013237896B2/en not_active Ceased
- 2013-03-29 EP EP13716919.9A patent/EP2830645B1/en active Active
- 2013-03-29 JP JP2015503646A patent/JP6420233B2/ja not_active Expired - Fee Related
- 2013-03-29 IL IL288785A patent/IL288785B2/en unknown
- 2013-03-29 PL PL17187879T patent/PL3278811T3/pl unknown
- 2013-03-29 US US14/389,655 patent/US20150094263A1/en not_active Abandoned
- 2013-03-29 ES ES13716919.9T patent/ES2647917T3/es active Active
- 2013-03-29 CN CN201380026579.2A patent/CN104321072A/zh active Pending
- 2013-03-29 CN CN201610027758.3A patent/CN106511971A/zh active Pending
- 2013-03-29 PT PT137169199T patent/PT2830645T/pt unknown
- 2013-03-29 PT PT171878796T patent/PT3278811T/pt unknown
- 2013-03-29 CA CA2869070A patent/CA2869070A1/en active Pending
- 2013-03-29 PL PL13716919T patent/PL2830645T3/pl unknown
- 2013-03-29 WO PCT/US2013/034634 patent/WO2013149163A1/en not_active Ceased
- 2013-03-29 EP EP17187879.6A patent/EP3278811B1/en active Active
- 2013-03-29 ES ES17187879T patent/ES2857810T3/es active Active
- 2013-03-29 NZ NZ700546A patent/NZ700546A/en not_active IP Right Cessation
- 2013-03-29 BR BR112014024308-5A patent/BR112014024308B1/pt not_active IP Right Cessation
- 2013-03-29 DK DK13716919.9T patent/DK2830645T3/da active
- 2013-03-29 EP EP20211026.8A patent/EP3842059A1/en not_active Withdrawn
- 2013-03-29 MX MX2014011838A patent/MX354598B/es active IP Right Grant
-
2014
- 2014-09-29 IL IL234882A patent/IL234882B/en active IP Right Grant
-
2015
- 2015-12-22 US US14/978,287 patent/US20160346353A1/en not_active Abandoned
-
2017
- 2017-04-07 JP JP2017076415A patent/JP2017149746A/ja active Pending
-
2018
- 2018-01-24 AU AU2018200592A patent/AU2018200592A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019070976A patent/JP2019131582A/ja active Pending
- 2019-04-05 AU AU2019202401A patent/AU2019202401B2/en not_active Ceased
-
2020
- 2020-03-09 IL IL273186A patent/IL273186B/en unknown
- 2020-10-30 AU AU2020260539A patent/AU2020260539A1/en not_active Abandoned
-
2021
- 2021-01-15 JP JP2021004728A patent/JP7108724B2/ja active Active
-
2022
- 2022-03-28 US US17/705,840 patent/US20230117985A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281833A (en) | Treatment of AMD with AAV SFLT-1 | |
| IL266159A (en) | Treatment of circadian rhythm disorders | |
| PL3278811T3 (pl) | Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych | |
| IL233714A0 (en) | Treatment of diseases related to the circadian rhythm | |
| SI2879672T1 (sl) | Kombinirana terapija za zdravljenje multiple skleroze | |
| EP2675460A4 (en) | TREATMENT OF FAT TISSUE UNDER CHIN | |
| GB201506561D0 (en) | Treatment of amblyopia | |
| EP2869833A4 (en) | TREATMENT OF INFLAMMATORY SKIN DISORDERS | |
| IL235984A0 (en) | Causes prophylactic and/or medical treatment of peripheral neuropathic pain caused by an anticancer drug | |
| PL2892556T3 (pl) | Kompozycje i sposoby odnoszące się do leczenia chorób | |
| ZA201408057B (en) | Compositions and methods for the treatment of moderate to severe pain | |
| IL239429A0 (en) | Use of fidotimide to treat psoriasis | |
| GB201107467D0 (en) | Novel treatment of pain | |
| EP2892612B8 (en) | Device for non-invasive vagal nerve stimulation to treat disorders | |
| GB201208505D0 (en) | Treatment of skin condition | |
| GB201208503D0 (en) | Treatment of a skin condition |